Antihistamine Superpotency Recall: Are You At Risk?

Antihistamine Superpotency Recall: Are You At Risk?

Antihistamine Superpotency Recall: Are You At Risk?

Quick read below — save or share if useful.

Allergy Medication Recall in 2 States: A Close Call for Consumers

After more than a year of uncertainty, the U.S. Food and Drug Administration (FDA) has finally completed a recall affecting nearly 120,000 units of over-the-counter (OTC) allergy medications produced by BLI International, Inc. The recall involved 4,901 cases of tablets containing 24 bottles each, totaling 117,624 bottles, that were sold to private label customers in Ohio and Missouri. This incident shed light on the dangers of superpotent drugs and the potential risks associated with improper dosages in over-the-counter medications.

This week's announcement marks the completion of the recall process, indicating that the firm has successfully retrieved all the affected products. The recall was initiated due to a "superpotency" issue, where testing revealed that the drugs contained higher-than-acceptable levels of the active ingredient, Chlorpheniramine Maleate.

Chlorpheniramine Maleate tablets are commonly used to alleviate allergy symptoms such as sneezing, runny nose, and itchy eyes by blocking histamine release during allergic reactions. However, excessive doses of antihistamines like Chlorpheniramine can pose serious health risks. The Cleveland Clinic warns that first-generation antihistamines, particularly those that induce drowsiness, can lead to overdose and potential adverse effects.

  • National Drug Code (NDC): 53185-277-24
  • Lot Number: 24A27724
  • Expiration Date: January 31, 2027

The recalled medications were distributed by Athlete's Needs, a Michigan-based company specializing in health products. The recall underscores the importance of stringent quality control measures in the pharmaceutical industry to prevent incidents like this from recurring.

Although no further action is required at the consumer level, it is crucial to remain vigilant about the potential risks of medication errors. Symptoms of antihistamine overdose can range from intense drowsiness and hallucinations to seizures and even fatality. Prompt medical attention is necessary if such symptoms occur.

In conclusion, the recall of superpotent allergy medication in Ohio and Missouri serves as a sobering reminder of the importance of rigorous quality assurance processes in drug manufacturing. Consumers must remain informed about the risks associated with over-the-counter medications and seek professional advice when in doubt about proper dosage and usage. Stay safe, stay informed, and prioritize your health above all else.

For more health updates and expert advice, subscribe to The Healthy newsletter and follow us on Facebook and Instagram. Remember, your well-being is paramount, so stay informed and make informed choices for a healthier lifestyle.

Follow & Connect
Explore My Other Blogs

Enjoyed this post? Share it or explore more across my blogs and channels.

Hi, I’m Ciro Irmici, an entrepreneur and investor from San Severo, Italy. My passions range from investments (stocks, crypto, dividends) to automation and creating businesses that help people. I believe in building things that matter, like a gym for all and a theatre for people to enjoy music. I love learning and sharing what I learn: how to create eBooks, audiobooks, and other digital products. I’m also deeply into fitness (gym, running, jump rope) and creativity (painting, music, design). My ultimate goal? To reach financial freedom and help others achieve their dreams.

Comments

Post a Comment